Mesangial cell dysfunction as a pathogenesis of diabetic nephropathy

Contributions to Nephrology

Volumn 134, Issue , 2001, Pages 16-29

  Haneda, Masakazu ^a   Koya, Daisuke ^a   Kikkawa, Ryuichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; SLC2A1 PROTEIN, HUMAN;

ANIMAL; DIABETIC NEPHROPATHY; HUMAN; MESANGIUM; METABOLISM; PATHOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; DIABETIC NEPHROPATHIES; DIGLYCERIDES; GLOMERULAR MESANGIUM; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MONOSACCHARIDE TRANSPORT PROTEINS; PROTEIN KINASE C;

EID: 0035538618     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060149     Document Type: Article

References (62)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
3. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998;339:69-75.
4. Fioretto P, Steffes MW, Mauer M: Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 1994;43:1358-1364.
5. Steffes MW, Osterby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989;38:1077-1081.
6. Mogensen CE: Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Invest 1971;28:91-100.
7. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981;21:683-688.
8. Haralson MA, Jacobson HR, Hoover RL: Collagen polymorphism in cultured rat kidney mesangial cells. Lab Invest 1987;57:513-523.
9. Ardaillou N, Bellon G, Nivez M-P, Rakotoarison S, Ardaillou R: Quantification of collagen synthesis by cultured human glomerular cells. Biochim Biophys Acta 1989;991:445- 452.
10. Ausiello DA, Kreisberg JI, Roy C, Karnovsky MJ: Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and vasopressin. J Clin Invest 1980;65:754-760.
11. Blantz RC, Konnen KS, Tucker BJ: Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest 1976;57:419- 434.
12. Ayo SH, Radnik RA, Garoni J, Glass WF II, Kreisberg JI: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 1990;136:1339-1348.
13. Ayo SH, Radnik RA, Glass WF II, Garoni J, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high glucose medium. Am J Physiol 1991;260:F185-F191.
14. Haneda M, Kikkawa R, Horide N, Togawa M, Koya D, Kajiwara N, Ooshima A, Shigeta Y: Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 1991;34:198-200.
15. Kikkawa R, Kitamura E, Fujiwara Y, Arimura T, Haneda M, Shigeta Y: Impaired contractile responsiveness of diabetic glomeruli to angiotensin II: A possible indication of mesangial dysfunction in diabetes mellitus. Biochem Biophys Res Commun 1986;136:1185-1190.
16. Menè P, Pugliese G, Pricci F, Di Mario U, Cinotti GA, Pugliese F: High glucose inhibits cytosolic calcium signaling in cultured rat mesangial cells. Kidney Int 1993;43:585-591.
17. Haneda M, Kikkawa R, Koya D, Uzu T, Maeda S, Togawa M, Shigeta Y: Alteration of mesangial response to ANP and angiotensin II by glucose. Kidney Int 1993;44:518-526.
18. Schambelan M, Blake S, Sraer J: Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest 1985;75:404-412.
19. Craven PA, Patterson MC, DeRubertis FR: Role of enhanced arachidonate availability through phospholipase A2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 1988;37:429-435.
20. Williams B, Schrier RW: Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 1993; 92:2889-2896.
21. Wakisaka M, He Q, Spiro MJ, Spiro Rj: Glucose entry into rat mesangial cells is mediated by both Na -coupled and facilitative transporters. Diabetologia 1995; 38:291-297.
22. Heilig CW, Liu Y, England RL, Freytag SO, Gilbert JD, Heilig KO, Zhu M, Concepcion LA, Brosius FC III: D-Glucose stimulates mesangial cell GLUT1 expression and basal and IGF-1-sensitive glucose uptake in rat mesangial cells: Implications for diabetic nephropathy. Diabetes 1997;46:1030-1039.
23. Heilig CW, Conception LA, Riser BL, Freytag SO, Zhu M, Cortes P: Overexpression of glucose transporter in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 1995;96:1802-1814.
24. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM: TGF-β inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 1993;74:1009-1020.
25. Inoki K, Haneda M, Maeda S, Koya D, Kikkawa R: TGF-β1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney Int 1999;55:1704-1712.
26. Kikkawa R, Umemura K, Haneda M, Kajiwara N, Maeda S, Nishimura C, Shigeta Y: Identification and characterization of aldose reductase in cultured rat mesangial cells. Diabetes 1992;41:1165-1171.
27. Beyer-Mears A, Ku L, Cohen MP: Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil. Diabetes 1984;33:604-607.
28. Cohen MP, Dasmahapatra A, Shapiro E: Reduced glomerular sodium/potassium adenosine triphosphatase activity in acute streptozocin diabetes and its prevention by oral sorbinil. Diabetes 1985;34:1071-1074.
29. Kikkawa R, Umemura K, Haneda M, Arimura T, Ebata K, Shigeta Y: Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes 1987;36:240-243.
30. Bank N, Moywer P, Aynedjian HS, Wikes BM, Silverman S: Sorbinil prevents glomerular hyperperfusion in diabetic rats. Am J Physiol 1989;256:F1000- F1006.
31. Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman WR, Kilo C, Williamson JR: Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes 1989;37:1258-1270.
32. Pedersen MM, Christiansen JS, Mogensen CE: Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo aldose reductase inhibition. Diabetes 1991; 40: 527-531.
33. Passariello N, Sepe J, Marrazzo G, Cicco AD, Peluso A, Pisano MCA, Sgambato S, Tesauro P, D'Onofrio F: Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy. Diabetes Care 1993;16: 789-795.
34. Mauer SM, Steffes MW, Azar S, Brown DM: Effect of sorbinil on glomerular structure and function in long-term-diabetic rats. Diabetes 1989;38:839-846.
35. Itagaki I, Shimizu K, Kamanaka Y, Ebata K, Kikkawa R, Haneda M, Shigeta Y: The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats. Diabetes Res Clin Pract 1994;25:147-154.
36. Daniels BS, Hostetter TH: Aldose reductase inhibition and glomerular abnormalities in diabetic rats. Diabetes 1989;38:981-986.
37. Korner A, Celsi G, Eklof A-C, Linne T, Persson B, Aperia A: Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats. Diabetologia 1992;35:414-418.
38. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-614.
39. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 1998;47:859-866.
40. Kikkawa R, Haneda M, Uzu T, Koya D, Sugimoto T, Shigeta Y: Translocation of protein kinase C α and ζ in rat glomerular mesangial cells cultured under high glucose condition. Diabetologia 1994;37:838-841.
41. Haneda M, Kikkawa R, Horide N, Togawa M, Koya D, Kajiwara N, Ooshima A, Shigeta Y: Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 1991;34:198-200.
42. Studer RK, Craven PA, Derubertis FR: Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 1993;42: 118-126.
43. Ayo SH, Radnik RA, Glass WF II, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 1991;260:F185-F191.
44. Fumo P, Kuncio GS, Ziyadeh FN: PKC and high glucose stimulate collagen alpha 1 (IV) transcriptional activity in a reporter mesangial cell line. Am J Physiol 1994;267:F632-F638.
45. Hurst RD, Stevanovic ZS, Munk S, Derylo B, Zhou X, Meer J, Silverberg M, Whiteside CI: Glomerular mesangial cell altered contractility in high glucose is Ca independent. Diabetes 1995; 44:759-766.
46. Pfeilschifter J: Tumour promotor 12-O-tetradecanoylphorbol 13-acetate inhibits angiotensin II-induced inositol phosphate production and cytosolic Ca rise in rat renal mesangial cells. FEBS Lett 1986;203:262-266.
47. Pfeilschifter J: Protein kinase C from rat mesangial cells: Its role in homologous desensitization of angiotensin II-induced polyphosphoinositide hydrolysis. Biochim Biophys Acta 1988;969:263-270.
48. Studer RK, Craven PA, DeRubertis FR: Activation of protein kinase C reduces thromboxane receptors in glomeruli and mesangial cells. Kidney Int 1993;44:58-64.
49. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 1996;272:728-731.
50. Haneda M, Sugimoto T, Kikkawa R: Mitogen-activated protein kinase phosphatase: A negative regulator of the mitogen-activated protein kinase cascade. Eur J Pharmacol 1999;365:1-7.
51. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R: Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 1997;46:847-853.
52. Lin L-L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ: cPLA2 is phosphorylated and activated by MAP kinase Cell 1993;72:269-278.
53. Isono M, Cruz MC, Chen S, Hong SW, Ziyadeh FN: Extracellular signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 2000;11:2222-2230.
54. Koya D, Lee I-K, Ishii H, King GL: Prevention of glomerular dysfunction in diabetic rats by treatment with d-a-tocopherol. J Am Soc Nephrol 1997;8:426-435.
55. Isshiki K, Haneda M, Koya D, Maeda S, Sugimoto T, Kikkawa R: Thiazolidine compounds ameliorate glomerular dysfunction independent of their insulin-sensirtizing action in diabetic rats. Diabetes 2000;49:1022-1032.
56. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL: Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 1997;100: 115-126.
57. Koya D, Haneda M, Nakagawa H, et al: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 2000;14:439-447.
58. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-beta in kidney diseases. Am J Physiol 1994;266:F829-F842.
59. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995;44:1139-1146.
60. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993;90:1814-1818.
61. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996;45:522-530.
62. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000;97:8015-8020.